|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
1983-5-5
|
|
pubmed:abstractText |
The effect of chemotherapy on bony metastases from adenocarcinoma of the colon was investigated by quantitative skeletal imaging over a two-month interval. The quantitative skeletal imaging results correlated with conventional blood chemistry results over this time period. While chemical assay techniques furnish an average value of lesion response, the quantitative bone scan represents a method for individual lesion analysis. This methodology has the potential to provide a better understanding of metastatic bone disease therapy.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0363-9762
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
8
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
11-3
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:6831814-Adenocarcinoma,
pubmed-meshheading:6831814-Antineoplastic Agents,
pubmed-meshheading:6831814-Bone Neoplasms,
pubmed-meshheading:6831814-Bone and Bones,
pubmed-meshheading:6831814-Colonic Neoplasms,
pubmed-meshheading:6831814-Diphosphonates,
pubmed-meshheading:6831814-Fluorouracil,
pubmed-meshheading:6831814-Germanium,
pubmed-meshheading:6831814-Humans,
pubmed-meshheading:6831814-Male,
pubmed-meshheading:6831814-Middle Aged,
pubmed-meshheading:6831814-Organometallic Compounds,
pubmed-meshheading:6831814-Spiro Compounds,
pubmed-meshheading:6831814-Technetium,
pubmed-meshheading:6831814-Technetium Compounds,
pubmed-meshheading:6831814-Time Factors
|
|
pubmed:year |
1983
|
|
pubmed:articleTitle |
The effects of chemotherapy on bony metastases as measured by quantitative skeletal imaging.
|
|
pubmed:publicationType |
Journal Article,
Case Reports
|
